Toth Financial Advisory Corp Sesen Bio, Inc. Transaction History

Toth Financial Advisory Corp

  • $817 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 20, 2020
SELL
$0.39 - $1.03 $195 - $515
-500 Closed
0 $0
Q4 2019

Jan 27, 2020
BUY
$0.89 - $1.5 $445 - $750
500 New
500 $1,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email